SOPHiA GENETICS expands AstraZeneca partnership for cancer detection
Go back to SOPHiA GENETICS expands AstraZeneca partnership for cancer detection| ASTRAZENECA PLC (NASDAQ: AZN) | Delayed: 92.77 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $92.77 | 52 Week High | $35.04 | |||
| Open | $92.77 | 52 Week Low | $26.97 | |||
| Day High | $92.77 | P/E | N/A | |||
| Day Low | $92.77 | EPS | $0.00 | |||
| Volume | 3,874,029 | |||||
| (NASDAQ: SOPH) | Delayed: 7.68 -0.68 (8.13%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.36 | 52 Week High | $ | |||
| Open | $8.37 | 52 Week Low | $ | |||
| Day High | $8.37 | P/E | N/A | |||
| Day Low | $7.64 | EPS | $ | |||
| Volume | 799,466 | |||||

